These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27555775)

  • 1. Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment.
    Königs A; Kiliaan AJ
    Neuropsychiatr Dis Treat; 2016; 12():1869-82. PubMed ID: 27555775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
    Parletta N; Niyonsenga T; Duff J
    PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD).
    Banaschewski T; Belsham B; Bloch MH; Ferrin M; Johnson M; Kustow J; Robinson S; Zuddas A
    Nutr Health; 2018 Dec; 24(4):279-284. PubMed ID: 29921155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids.
    Checa-Ros A; Haro-García A; Seiquer I; Molina-Carballo A; Uberos-Fernández J; Muñoz-Hoyos A
    Minerva Pediatr; 2019 Aug; 71(4):313-325. PubMed ID: 30419741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of ω-6 GLA Added to ω-3 PUFAs Supplements for ADHD: A Narrative Review.
    D'Helft J; Caccialanza R; Derbyshire E; Maes M
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
    Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
    Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of Attention-Deficit/Hyperactivity Disorders with polyunsaturated fatty acids - an effective treatment alternative?].
    Frölich J; Döpfner M
    Z Kinder Jugendpsychiatr Psychother; 2008 Mar; 36(2):109-16. PubMed ID: 18622940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents.
    Chang JP; Su KP
    Clin Psychopharmacol Neurosci; 2020 Nov; 18(4):469-483. PubMed ID: 33124582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake in Children with Attention Deficit and Hyperactivity Disorder.
    Fuentes-Albero M; Martínez-Martínez MI; Cauli O
    Brain Sci; 2019 May; 9(5):. PubMed ID: 31126106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis.
    Cooper RE; Tye C; Kuntsi J; Vassos E; Asherson P
    J Affect Disord; 2016 Jan; 190():474-482. PubMed ID: 26551407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says.
    Lange KW; Hauser J; Lange KM; Makulska-Gertruda E; Nakamura Y; Reissmann A; Sakaue Y; Takano T; Takeuchi Y
    Curr Psychiatry Rep; 2017 Feb; 19(2):8. PubMed ID: 28168597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis.
    Cooper RE; Tye C; Kuntsi J; Vassos E; Asherson P
    J Psychopharmacol; 2015 Jul; 29(7):753-63. PubMed ID: 26040902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation into the plasma concentration of ω3 polyunsaturated fatty acids in Japanese attention-deficit hyperactivity disorder patients.
    Yonezawa K; Nonaka S; Iwakura Y; Kusano Y; Funamoto Y; Kanchi N; Yamaguchi N; Kusumoto Y; Imamura A; Ozawa H
    J Neural Transm (Vienna); 2018 Sep; 125(9):1395-1400. PubMed ID: 29926268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of omega-3 polyunsaturated fatty acids on human brain morphology and function: What is the evidence?
    Bos DJ; van Montfort SJ; Oranje B; Durston S; Smeets PA
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):546-61. PubMed ID: 26742901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials.
    Puri BK; Martins JG
    Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):179-89. PubMed ID: 24560325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of dietary supplementation with natural ω-3 polyunsaturated fatty acids on the visual acuity of school-age children with lower IQ or attention-deficit hyperactivity disorder.
    Wu Q; Zhou T; Ma L; Yuan D; Peng Y
    Nutrition; 2015; 31(7-8):935-40. PubMed ID: 26015389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies.
    Chang JP; Su KP; Mondelli V; Pariante CM
    Neuropsychopharmacology; 2018 Feb; 43(3):534-545. PubMed ID: 28741625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.
    Rodríguez C; García T; Areces D; Fernández E; García-Noriega M; Domingo JC
    Neuropsychiatr Dis Treat; 2019; 15():1193-1209. PubMed ID: 31190827
    [No Abstract]   [Full Text] [Related]  

  • 19. Omega-3 fatty acids are inversely related to callous and unemotional traits in adolescent boys with attention deficit hyperactivity disorder.
    Gow RV; Vallee-Tourangeau F; Crawford MA; Taylor E; Ghebremeskel K; Bueno AA; Hibbeln JR; Sumich A; Rubia K
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jun; 88(6):411-8. PubMed ID: 23664595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Omega-3 and omega-6 fatty acids in the treatment of children and adolescents with ADHD].
    Aben A; Danckaerts M
    Tijdschr Psychiatr; 2010; 52(2):89-97. PubMed ID: 20146180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.